Alectinib hydrochloride
Products
Description
Alectinib is a second generation oral drug that selectively inhibits the activity of anaplastic lymphoma kinase (ALK) tyrosine kinase.
Specifications
| Manufacturer Cat# | S5232 |
|---|---|
| Pathway | Protein Tyrosine Kinase |
| Target | ALK |